187 related articles for article (PubMed ID: 11884932)
1. Proteinuria after injection of human focal segmental glomerulosclerosis factor.
Sharma M; Sharma R; Reddy SR; McCarthy ET; Savin VJ
Transplantation; 2002 Feb; 73(3):366-72. PubMed ID: 11884932
[TBL] [Abstract][Full Text] [Related]
2. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli.
McCarthy ET; Sharma M; Sharma R; Falk RJ; Jennette JC
J Lab Clin Med; 2004 Apr; 143(4):225-9. PubMed ID: 15085081
[TBL] [Abstract][Full Text] [Related]
3. Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria.
Le Berre L; Godfrin Y; Lafond-Puyet L; Perretto S; Le Carrer D; Bouhours JF; Soulillou JP; Dantal J
Kidney Int; 2000 Dec; 58(6):2502-11. PubMed ID: 11115084
[TBL] [Abstract][Full Text] [Related]
4. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.
Sharma M; Sharma R; McCarthy ET; Savin VJ
Exp Biol Med (Maywood); 2004 Jan; 229(1):85-98. PubMed ID: 14709781
[TBL] [Abstract][Full Text] [Related]
5. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro.
Sharma R; Sharma M; McCarthy ET; Ge XL; Savin VJ
Kidney Int; 2000 Nov; 58(5):1973-9. PubMed ID: 11044217
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.
Sharma M; Zhou J; Gauchat JF; Sharma R; McCarthy ET; Srivastava T; Savin VJ
Transl Res; 2015 Oct; 166(4):384-98. PubMed ID: 25843671
[TBL] [Abstract][Full Text] [Related]
7. "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.
Sharma M; Sharma R; McCarthy ET; Savin VJ
J Am Soc Nephrol; 1999 Mar; 10(3):552-61. PubMed ID: 10073606
[TBL] [Abstract][Full Text] [Related]
8. The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis.
Carraro M; Zennaro C; Artero M; Candiano G; Ghiggeri GM; Musante L; Sirch C; Bruschi M; Faccini L
Nephrol Dial Transplant; 2004 Aug; 19(8):1969-75. PubMed ID: 15187198
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome.
Carraro M; Zennaro C; Candiano G; Musante L; Bruschi M; Ghiggeri GM; Artero M; Faccini L
Nephrol Dial Transplant; 2003 Apr; 18(4):689-93. PubMed ID: 12637636
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP.
Sharma R; Sharma M; Ge X; McCarthy ET; Savin VJ
Transplantation; 1996 Dec; 62(12):1916-20. PubMed ID: 8990387
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis.
Artero ML; Sharma R; Savin VJ; Vincenti F
Am J Kidney Dis; 1994 Apr; 23(4):574-81. PubMed ID: 8154495
[TBL] [Abstract][Full Text] [Related]
12. Permeability factors in focal segmental glomerulosclerosis.
Savin VJ; McCarthy ET; Sharma M
Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
[TBL] [Abstract][Full Text] [Related]
13. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis.
Cattran D; Neogi T; Sharma R; McCarthy ET; Savin VJ
J Am Soc Nephrol; 2003 Feb; 14(2):448-53. PubMed ID: 12538746
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum.
McCarthy ET; Sharma M
Kidney Int; 2002 Feb; 61(2):534-41. PubMed ID: 11849393
[TBL] [Abstract][Full Text] [Related]
15. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys.
Feld SM; Figueroa P; Savin V; Nast CC; Sharma R; Sharma M; Hirschberg R; Adler SG
Am J Kidney Dis; 1998 Aug; 32(2):230-7. PubMed ID: 9708606
[TBL] [Abstract][Full Text] [Related]
17. Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli.
Musante L; Candiano G; Bruschi M; Zennaro C; Carraro M; Artero M; Giuffrida MG; Conti A; Santucci A; Ghiggeri GM
Proteomics; 2002 Feb; 2(2):197-205. PubMed ID: 11840565
[TBL] [Abstract][Full Text] [Related]
18. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria in rats induced by serum from patients with collapsing glomerulopathy.
Avila-Casado Mdel C; Perez-Torres I; Auron A; Soto V; Fortoul TI; Herrera-Acosta J
Kidney Int; 2004 Jul; 66(1):133-43. PubMed ID: 15200420
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach.
Moriconi L; Lenti C; Puccini R; Pasquariello A; Rindi P; Batini V; Carraro M; Zennaro C
Ren Fail; 2001; 23(3-4):533-41. PubMed ID: 11499567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
